Okay, let's tackle this question. The user wants a detailed explanation for a multiple-choice question about prostaglandin analogues used in glaucoma. First, I need to recall which prostaglandin analogues are used in ophthalmology for glaucoma. The main ones I remember are latanoprost, bimatoprost, and travoprost. These are commonly used as first-line treatments because they increase uveoscleral outflow of aqueous humor.

Now, the question is asking which of the options is correct. Since the options aren't provided, I have to assume the possible distractors. Common incorrect options might include other types of glaucoma medications like beta-blockers (e.g., timolol), alpha agonists (e.g., brimonidine), or maybe another prostaglandin that's not used for glaucoma. Alternatively, there might be a prostaglandin analogue used for other purposes, like misoprostol for ulcers or alprostadil for other conditions.

The core concept here is understanding the classification and use of prostaglandin analogues. The correct answer would be one of the glaucoma-specific ones. The explanation should highlight their mechanism of action, which is increasing uveoscleral outflow. For the incorrect options, I need to explain why they are wrong—maybe they are used for other conditions or belong to a different class.

Clinical pearls should mention that prostaglandin analogues are first-line due to their efficacy and once-daily dosing. Also, common side effects like darkening of the iris or eyelashes could be a point, but maybe that's more for the question's context. The key is to make sure the student remembers the correct drugs and differentiates them from other classes.

**Core Concept**
Prostaglandin analogues used in glaucoma reduce intraocular pressure by increasing uveoscleral outflow of aqueous humor. Key agents include latanoprost, bimatoprost, and travoprost, which act via FP prostaglandin receptors in the ciliary body.

**Why the Correct Answer is Right**
Latanoprost is a synthetic prostaglandin F2α analog. It binds to FP receptors in the ciliary epithelium, relaxing trabecular meshwork and enhancing uveoscleral outflow. This mechanism is distinct from beta-blockers or alpha agonists, which reduce aqueous production. Its once-daily dosing and efficacy make it a first-line therapy for open-angle glaucoma.

**Why Each Wrong Option is Incorrect**
**Option A:** Timolol is a beta-blocker; it reduces aqueous production but has no FP receptor activity.
**Option B:** Brimonidine is an alpha-2 agonist; it decreases aqueous formation and increases uveoscleral outflow indirectly.
**Option C:** Pilocarpine is a cholinergic agonist; it enhances trabecular outflow via pupillary constriction.
**Option D:** Misoprostol is a PGE1 analog used for gastric ulcers or labor induction, not glaucoma.

**Clinical Pearl / High-Yield Fact**
Prostaglandin analogues are first-line for glaucoma due to their potency and once-daily regimen. Side effects include iris hyperpig

✓ Correct Answer: B. Latanoprost